Association between Painful Physical Symptoms and Clinical Outcomes in Korean Patients with Major Depressive Disorder:A Three-Month Observational Study

被引:10
|
作者
Lee, Min Soo [2 ]
Yum, Sun Young [1 ]
Hong, Jin Pyo [3 ]
Yoon, Se Chang [4 ]
Noh, Jai Sung [5 ]
Lee, Kwang Hun [6 ]
Kim, Jung Ki [7 ]
Lee, Sang Yeol [8 ]
Singh, Pritibha [9 ]
Treuer, Tamas [10 ]
Reed, Victoria [9 ]
Raskin, Joel [11 ]
机构
[1] Eli Lilly & Co, Seoul, South Korea
[2] Korea Univ, Coll Med, Dept Psychiat, Seoul 136705, South Korea
[3] Univ Ulsan, Asan Med Ctr, Dept Psychiat, Seoul, South Korea
[4] Sungkyunkwan Univ, Samsung Med Ctr, Dept Neuropsychiat, Seoul, South Korea
[5] Ajou Univ, Sch Med, Dept Psychiat, Suwon 441749, South Korea
[6] Donguk Univ, Kyoungju Med Ctr, Dept Neuropsychiat, Gyeongju, South Korea
[7] Pusan Merinol Med Ctr, Dept Neuropsychiat, Pusan, South Korea
[8] Wonkwang Univ Hosp, Dept Psychiat, Iksan, South Korea
[9] Eli Lilly & Co, Intercontinental Informat Sci, Sydney, NSW, Australia
[10] Eli Lilly & Co, Budapest, Hungary
[11] Eli Lilly & Co, Lilly Res Labs, Toronto, ON, Canada
关键词
Pain; Depressive disorder; Major; Korea; Quality of life; Depression; Culture; TENSION-TYPE HEADACHE; PSYCHIATRIC-DISORDERS; SOMATIC SYMPTOMS; IMMIGRANT WOMEN; HWA-BYUNG; AMERICAN; EPIDEMIOLOGY; SOMATIZATION; PREVALENCE; DULOXETINE;
D O I
10.4306/pi.2009.6.4.255
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective This paper aims to examine the association between painful physical symptoms (ITS) and major depressive disorder (MDD) in a naturalistic clinical practice setting within a Korean population. Methods Patients with acute MDD that joined a multicountry, observational, three-month Study in six Asian countries and regions ere classified as PPS+ (mean score >= 2) and PPS- (mean score <2) using the modified Somatic Symptom Inventory. In this analysis, we report, the results from the Korea,, subset, where depression severity was assessed using the Clinical Global Impression of Severity (CGI-S) scale and 17-item Hamilton Depression Rating Scale (HAMD(17)) Pain severity was measured using a Visual analogue scale (VAS), while the EuroQoL (EQ-5D) assessed patient well-being. Results Of 198 patients, 45.96% (91/198) of patients were classified as PPS+ of which, 78.02% (71/91) were women. PPS+ patients had significantly more severe depression at baseline {CGI-S score, mean [standard deviation (SD)], PPS+: 5.09 [0.79]; PPS-: 4.63 [0.76]; p<0.001; HAMD(17) total score, mean [SD], PPS+: 24.34 [5.24]; PPS-: 20.76 [5.12]; p<0.001} and poorer quality of life [EQ-5D overall health state, mean (SD), PPS+: 39.37 (20.52); PPS-: 51.27 [20.78]; p<0.001] than PPS- patients. Both groups improved significantly (p<0.001) in depression and pain severity outcomes, as well as quality of life by end-point, but 110 significant within-group baseline-to-endpoint change wase observed. Conclusion The frequency of PPS was common in Korean patients with MDD and was, associated with more severe depression, poorer quality of life, and a trend towards poorer clinical outcome. Psychiatry Invest 2009;6:255-263
引用
收藏
页码:255 / 263
页数:9
相关论文
共 50 条
  • [31] Distorted thoughts as a mediator of depressive symptoms in patients with major depressive disorder: a longitudinal study
    Carneiro, Adriana Munhoz
    Pereira, Danilo Assis
    Fernandes, Fernando
    Baptista, Makilim Nunes
    Brunoni, Andre Russowsky
    Moreno, Ricardo Alberto
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2023, 21 (01)
  • [32] Distorted thoughts as a mediator of depressive symptoms in patients with major depressive disorder: a longitudinal study
    Adriana Munhoz Carneiro
    Danilo Assis Pereira
    Fernando Fernandes
    Makilim Nunes Baptista
    André Russowsky Brunoni
    Ricardo Alberto Moreno
    Health and Quality of Life Outcomes, 21
  • [33] Longitudinal associations between depressive symptoms and clinical factors in ankylosing spondylitis patients: analysis from an observational cohort
    Hwang, Mark C.
    Lee, Min Jae
    Gensler, Lianne S.
    Ward, Michael M.
    Brown, Matthew A.
    Eisen, Seth
    Learch, Thomas J.
    Tahanan, Amirali
    Rahbar, Mohammad H.
    Ishimori, Mariko L.
    Weisman, Michael H.
    Reveille, John D.
    RHEUMATOLOGY INTERNATIONAL, 2020, 40 (07) : 1053 - 1061
  • [35] An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life
    Kuga, Atsushi
    Tsuji, Toshinaga
    Hayashi, Shinji
    Fujikoshi, Shinji
    Tokuoka, Hirofumi
    Yoshikawa, Aki
    Escobar, Rodrigo
    Tanaka, Kazuhide
    Azekawa, Takaharu
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 2115 - 2124
  • [36] A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical
    Gaynor, Paula J.
    Gopal, Murali
    Zheng, Wei
    Martinez, James M.
    Robinson, Michael J.
    Marangell, Lauren B.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (10) : 1849 - 1858
  • [37] Cross-national differences in hypochondriasis symptoms between Korean and American outpatients with major depressive disorder
    Chang, Kyung-Ah Judy
    Kim, Kiwon
    Fava, Maurizio
    Mischoulon, David
    Hong, Jin Pyo
    Kim, Daniel J. H.
    Heb, Jung-Yoon
    Choi, Hong
    Jeon, Hong Jin
    PSYCHIATRY RESEARCH, 2016, 245 : 127 - 132
  • [38] The association between lower urinary tract symptoms and depressive symptoms in older Korean adults: a cross-sectional study
    Lim, Do Gyeong
    Yu, Seong Hyeon
    Kim, Ju-Wan
    Han, Jae-Young
    Shin, Min -Ho
    Park, Kwangsung
    JOURNAL OF MENS HEALTH, 2024, 20 (06) : 78 - 84
  • [39] Safety and Effectiveness of Desvenlafaxine in Korean Patients with Major Depressive Disorder: A 6-month Postmarketing Surveillance Study
    Roh, Sungwon
    Lee, Kang Soo
    Choi, Songhwa
    Kim, Jae-Min
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2022, 20 (03) : 548 - 559
  • [40] Anxiety symptoms in working patients with major depressive disorder treated with vortioxetine: associations with clinical and treatment outcomes in the AtWoRC study
    Chokka, Pratap
    Ge, Holly
    Bougie, Joanna
    Ettrup, Anders
    Clerzius, Guerline
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2021, 11